Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Reduced by Prime Capital Investment Advisors LLC

Prime Capital Investment Advisors LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,828 shares of the pharmacy operator’s stock after selling 1,856 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Walgreens Boots Alliance were worth $97,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WBA. Iron Horse Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 1,300 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the last quarter. Continuum Advisory LLC lifted its position in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares during the last quarter. Sentry Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the third quarter worth about $30,000. Finally, Eastern Bank acquired a new stake in shares of Walgreens Boots Alliance in the third quarter worth about $33,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on WBA shares. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. UBS Group boosted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Morgan Stanley cut their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. Bank of America cut their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Finally, TD Cowen cut their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Trading Down 3.7 %

WBA stock opened at $8.48 on Monday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.22 and a 1-year high of $27.05. The firm has a market cap of $7.33 billion, a P/E ratio of -0.85, a P/E/G ratio of 1.11 and a beta of 0.69. The business’s 50 day moving average is $9.19 and its 200-day moving average is $11.83. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period in the prior year, the company posted $0.67 EPS. The company’s revenue was up 5.9% compared to the same quarter last year. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be given a dividend of $0.25 per share. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 11.79%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.